11/06/2018

Newsletters of Interest

A Few Articles You Won’t Want to Miss:

• Submit your precertification clinical information online
• Clinical payment and coding policy changes
• Our office manual keeps you informed
• Don’t let your network status change — complete your FDR attestation today
• Changes to commercial drug lists begin on January 1, 2019

And Much More….SEPTEMBER Mid-America Region Qtly Issue Available HERE

A Few Articles You Won’t Want to Miss:

• Blue Care Network will continue to offer 19 products for individual marketplace in 2019
• We’ve made improvements to Provider Inquiry
• Reminder: Starting Oct. 1, additional specialty medications required authorization for BCN Advantage^SM members
• BCN Advantage initiating step therapy to certain Part B specialty drugs on the prior authorization program beginning in January
• Specialty pharmacy program helps you care for your patients

And Much More…NOVEMBER/DECEMBER Bi-Monthly Issue Available HERE

Current Issue Available HERE

Current Issue Available HERE   (once on the site, choose NEWS on the left side)

A Few Articles You Won’t Want to Miss:

• Complete 2018 Compliance Training Today
• Note Important Information for Dual-eligible Benefit Coordination
• Learn About the Humana Medicare Advantage Peer-to-Peer Review and Provider Dispute Processes
• New and Revised Pharmacy and Medical Coverage Policies Available

And Much More…Latest Issue Available HERE

 A Few Articles You Won’t Want to Miss:

• Front & Center
  • Billing for Intravenous and Subcutaneous Immune Globulin and Remicade^®
  • Prescription Drug List Updates
  • UnitedHealthcare Commercial and UnitedHealthcare Community Plan Outpatient Injectable Cancer Therapy Authorization Program Update

• UnitedHealthcare Commercial
  • Peer Comparison Reports Available in November 2018

• UnitedHealthcare Reimbursement Policies
  • Update on Injection and Infusion Services Policy

And Much More…NOVEMBER Monthly Issue Available HERE

Oncology Related Articles You Won’t Want to Miss:

Medical Policy Updates

Updated:

• Apheresis - Effective Nov. 1, 2018

Revised:

• Genetic Testing for Hereditary Cancer - Effective Dec. 1, 2018

Medical Benefit Drug Policy Updates

Revised:

• Clotting Factors and Coagulant Blood Products - Effective Nov. 1, 2018
• Denosumab (Prolia^®  & Xgeva^®) - Effective Nov. 1, 2018
• Immune Globulin (IVIG and SCIG) - Effective Nov. 1, 2018
• Ocrevus™ (Ocrelizumab) - Effective Nov. 1, 2018
• White Blood Cell Colony Stimulating Factors - Effective Nov. 1, 2018

Utilization Review Guideline (URG) Updates

New:

• Magnetic Resonance Imaging (MRI) and Computed Tomography (CT) Scan - Site of Care - Effective Jan. 1, 2019

NOVEMBER Monthly Issue Available HERE